Berlin-Chemie AG is a German pharmaceutical company based in
Berlin
Berlin ( , ) is the capital and List of cities in Germany by population, largest city of Germany by both area and population. Its 3.7 million inhabitants make it the European Union's List of cities in the European Union by population within ci ...
, Germany. It is part of the
Menarini Group.
History
Berlin-Chemie considers the establishment of a plant for the laboratory preparations of the Chemical factory of Kahlbaum in Berlin-
Adlershof
Adlershof (, literally "Eagle's Court") is a locality (') in the borough (') Treptow-Köpenick of Berlin, Germany.
Adlershof is home to the new City of Science, Technology and Media ( WISTA), located on the southwestern edge of the locality.
...
in 1890, as its origin. The first factory located in the former administrative district of
Treptow
Treptow () was a former borough in the southeast of Berlin. It merged with Köpenick to form Treptow-Köpenick in 2001.
Geography
The district was composed by the localities of Alt-Treptow, Plänterwald, Baumschulenweg, Niederschöneweide, J ...
, Berlin-Adlershof. In 1927 after the merger with
Schering AG
Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006, it was bought by Bayer AG and merged to form the Bayer subs ...
employees began the development of drugs. When the state-owned companies were privatized or dissolved after the political turnaround, the Italian group Menarini took over the factory in Berlin in 1992, including the product name, and thus immediately found a larger sales market in Eastern Europe.
Products
In February 2013, Berlin-Chemie took over the Priligy brand, a drug against premature ejaculation. Since mid-2013, there has been a media campaign on the internet and through posters on the subject of premature ejaculation, which many physicians are critical of. According to the imprint of the website in question, Later Come.de, this is a media contribution by Berlin-Chemie AG.
Since 2015, Berlin-Chemie has been able to manufacture and sell anti-cancer drugs through a license agreement with the Japanese drug manufacturer
Chugai.
The production of infusion solutions was discontinued in 2019.
References
External links
*
Manufacturing companies based in Berlin
Pharmaceutical companies of Germany
{{Company-stub